Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various

Jerry Altshuler1, David J Guervil2, Charles D Ericsson3

  • 11 Pharmacy Department, Mount Sinai Beth Israel, New York, NY, USA.

Abstract

Insights

Cefepime treatment failure increased for gram-negative infections with minimum inhibitory concentrations (MICs) of 4-8 μg/mL. Higher cefepime doses may be needed for these elevated MICs, challenging current guidelines.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Microbiology

Background:

  • Clinical and Laboratory Standards Institute (CLSI) updated cefepime susceptibility criteria in 2014.
  • New criteria include a susceptible dose-dependent category for Enterobacteriaceae with minimum inhibitory concentrations (MICs) of 4-8 μg/mL.
  • Limited clinical data exist to support these revised cefepime interpretive criteria.

Purpose of the Study:

  • To compare clinical outcomes in patients treated with standard versus high-dose cefepime.
  • To evaluate cefepime efficacy across different MICs for gram-negative organisms.
  • To assess the impact of revised CLSI cefepime breakpoints on treatment outcomes.

Main Methods:

  • Retrospective review of 90 patients with pneumonia or bacteremia caused by gram-negative organisms.
  • Patients received adequate cefepime doses for ≥48 hours.
  • Outcomes analyzed based on cefepime MICs: ≤2 μg/mL (low), 4 μg/mL (medium), and 8 μg/mL (high).

Main Results:

  • Multivariate analysis showed increased clinical failure in patients with medium (OR: 9.13) and high (OR: 6.79) MICs.
  • 46 patients had low MICs, 25 had medium MICs, and 19 had high MICs.
  • Both medium and high MIC groups demonstrated statistically significant higher rates of clinical failure.

Conclusions:

  • Cefepime therapy, even at standard doses, is associated with higher clinical failure risk for gram-negative pathogens with MICs of 4 or 8 μg/mL.
  • Current CLSI-recommended doses may be insufficient for infections with elevated cefepime MICs.
  • Higher cefepime dosing regimens (e.g., 2g q8h or 1g q6h) might be required for serious gram-negative infections with higher MICs.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
277
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
1.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
280
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
270
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
563
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
234